Probably not the anniversary present the government was hoping to offer the public.

Leaving the EU will damage health in this country where it was suffering the most before the pandemic, and where covid-19 hit it hardest, says Martha McCarey.

The government has announced the plans – but hasn't decided what form of transport will be used.

THE turning point was the Brexit referendum. Before voting to leave the EU in June 2016, medicine shortages were not something the UK often had to worry about.

With the NHS under such exceptional pressure during the coronavirus crisis, it’s easy to overlook the fact that the UK’s Brexit transition period ends on December 31. Mark Dayan takes a closer look at how these two challenges for the health service might collide, and says there is a case to err on the side of caution.

The people of Scotland must be given a choice about their future given the damage inflicted by Brexit, Constitution Secretary Angus Robertson has said. / Marking two years since the end of the transition period to leave the European Union after 47 years of membership, Mr Robertson highlighted the negative impacts Brexit continues to have on Scotland’s economy.

In an exclusive interview with the Record, Dr Arianna Andreangeli tells how the NHS has further deteriorated since Brexit. / Scotland is facing a crisis in its National Health Service due to Covid and Tory austerity - but Brexit has caused further deadly delays in our hospitals.

Brexit has worsened doctor shortages in the UK, according to a study published on Sunday.

Brexit shut off the “relief valve” of immigration from the European Union, worsening workforce shortages in health and social care in the UK, a report from the Nuffield Trust think tank has concluded. / Brexit’s effect has been felt particularly in specialties such as cardiothoracic surgery and anaesthesia, and in dentistry and the care sector.

A report is warning the UK's medicine supply chain is "broken" with drug shortages becoming the "new normal" in Britain.

A report from the Nuffield Trust has concluded that the UK is facing “constantly elevated medicine shortages,” including some antibiotics and epilepsy drugs, which are being fuelled by Brexit.

Brexit has increased drug prices and worsened staff shortages in the U.K., increasing the impact of other serious issues facing the country’s health care system, a report has found.

THE SEISMIC CHANGES to the relationship with our nearest neighbours and the impact of Brexit have only added fuel to the fire of severe challenges facing health and social care in the UK today, making people less healthy and widening health inequalities.

There are growing post-Brexit differences between which medicines are approved for use in Northern Ireland and the rest of the UK, research from a health think tank indicates.

From NHS staff shortages to export woes, the effects of the 2016 vote are still being felt.

Bloc plans to bulk-buy key drugs for all 27 countries, potentially leaving Britain ‘behind in the queue’. / “Europe is securing access to key drugs and vaccines as a single region, with huge influence and buying power. As a result of Brexit the UK is now isolated from this system, so our drug supplies could be at risk in the future,” said Dr Andrew Hill, an expert on the pharmaceutical trade.

It comes as figures from the NHS show there are 10,582 FTE medical vacancies across England alone. / More than 4,000 European doctors have opted not to work in the NHS following the Brexit vote in 2016, research has revealed.

Medical supplies crucial to fight a second wave of coronavirus face being disrupted by a no-deal Brexit, a leading health think tank has warned.

Price of X-ray machines, medicines and bedding all expected to rise, says Nuffield Trust.

Patients put at risk as crisis hits supplies of vital antibiotics, HRT and anti-depressants. / Vital antibiotics, hormone replacement therapy (HRT) and attention deficit hyperactivity disorder (ADHD) drugs are among those in desperately short supply this winter – with the NHS forced to pay over the odds to get drugs into Britain.

Hospital chiefs have been asked to prepare health service for potential disruption from end of 2020.

Specialisms such as dentistry have shortages and EU exit still causes issues with medicines in Northern Ireland, thinktank finds.

There are still unresolved issues with the Northern Ireland Protocol despite changes made by the EU, says a major pharmaceutical firm.

This being 2020, it didn't take long for good news about the Pfizer/BioNTech jab to turn into a tiresome row about Brexit.

The Nuffield Trust think tank has published a new report on the impact of Brexit on the UK’s health and care services. The ongoing monitoring work, funded by the Health Foundation, covers the impact on the NHS and social care workforce, medicine and medical devices supply and the economic cost, and reveals negative effects across these areas.

Our report published today looks at six key areas of health and social care that are being impacted by Brexit.

The UK's split with the EU has worsened recruitment shortages while pushing up the price of some medicines.

Hundreds of researchers and organisations across Europe have called for the rapid association of the UK and Switzerland to Horizon Europe.

‘The medicines supply chain is broken at every level,’ warns Dr Leyla Hannbeck.

More than 4,000 European doctors have opted not to work in the NHS following the Brexit vote in 2016, research has revealed.

Six years after the referendum we can disentangle the evidence and judge the effects on health and care, says Richard Vize.

Five years on from the Brexit vote, Mark Dayan looks back at the main claims that were made about the NHS before the referendum took place. Which have been proven right and which have proven to be unfounded?

The impact of Brexit has only added fuel to the fire of severe challenges facing health and social care in the UK, warns the Nuffield Trust.

For almost 50 years, the NHS benefited from easy access to a large market, meaning it’s been first in the queue for the latest innovations. But what impact might Brexit have on medicines, medical devices and life sciences in the UK? Mark Dayan explains, in a blog that was first published in the BMJ on 26 February.

Sam Bright examines the contribution of Brexit to our current healthcare crisis.

The U.K. has missed out on recruiting thousands of European doctors since voting to leave the economic union in 2016, research from a health thinktank suggests.

British pharmacists are struggling to get their hands on certain medicines for cancer, epilepsy, diabetes and menopause as drug supply issues intensify in the country.

THE UK GOVERNMENT’S RESPONSE to Brexit and its failure to iron out key agreements after nearly a year outside the Single Market and Customs Union, are fuelling constant uncertainty over many aspects of health and social care in the UK, says a new report from the Nuffield Trust.

EU moves to guarantee supply of medicines to Northern Ireland have so far worked but there are looming issues, peers have heard.

Mr Johnson told his cabinet this week that leaving the EU without a deal should hold “no fear” for Britain, but was he right?

Britain will continue trying to recruit the health workers it needs from abroad, but getting back those its lost to the EU is unlikely - as ITV News Europe Editor James Mates reports.